Correlation between Choline Signal Intensity and Acetylcholine Level in Different Brain Regions of Rat
暂无分享,去创建一个
Qing Tian | Q. Tian | Jian-Zhi Wang | Xiaofeng Du | Jian-Zhi Wang | Xiao-Chuan Wang | Xiao-Xia Du | Xiao-Chuan Wang
[1] M. Bakovic,et al. Choline Transport for Phospholipid Synthesis , 2006 .
[2] David G. Gadian,et al. Nuclear magnetic resonance and its applications to living systems , 1982 .
[3] M. Giovannini,et al. Serotonergic modulation of acetylcholine release from cortex of freely moving rats. , 1998, The Journal of pharmacology and experimental therapeutics.
[4] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[5] B. Hoebel,et al. Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus , 1995, Brain Research.
[6] P. Calabresi,et al. Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine , 2006, Neuropharmacology.
[7] M. Miranda,et al. Cortical cholinergic activity is related to the novelty of the stimulus , 2000, Brain Research.
[8] J. Coyle,et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.
[9] P. E. Gold. Acetylcholine modulation of neural systems involved in learning and memory , 2003, Neurobiology of Learning and Memory.
[10] M. Sarter,et al. Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention , 2002, Neuroscience.
[11] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[12] W. Greenough,et al. Synaptic plasticity in cortical systems , 1999, Current Opinion in Neurobiology.
[13] E. Giacobini. Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications , 1998, Neurochemistry International.
[14] K. Blennow,et al. CSF markers for pathogenic processes in Alzheimer’s disease: diagnostic implications and use in clinical neurochemistry , 2003, Brain Research Bulletin.
[15] C. Gong,et al. Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit , 2004, Neuroscience.
[16] Alexei R. Koudinov,et al. Direct detection of brain acetylcholine synthesis by magnetic resonance spectroscopy , 2005, Brain Research.
[17] I. Grundke‐Iqbal,et al. Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.
[18] S. Arnold,et al. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? , 2005, Trends in pharmacological sciences.
[19] M. Ragozzino. Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns , 2003, Neurobiology of Learning and Memory.
[20] M. Mesulam. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? , 2004, Learning & memory.
[21] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[22] Stanley J. Watson,et al. The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.
[23] J. Trojanowski,et al. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.
[24] Mathias Hoehn,et al. Correlation between MR-spectroscopic rat hippocampal choline levels and phospholipase A2 , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[25] P. Cras,et al. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. , 1990, The American journal of pathology.
[26] S. Ando,et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats , 2001, Journal of neuroscience research.
[27] Brian D. Ross,et al. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .
[28] A. Persico,et al. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo , 2005, Journal of Neural Transmission / General Section JNT.
[29] R. Quirion,et al. Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.
[30] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[31] F. LaFerla,et al. Alzheimer's disease: Aβ, tau and synaptic dysfunction , 2005 .
[32] T. Robbins,et al. Central cholinergic systems and cognition. , 1997, Annual review of psychology.
[33] J. S. Benton,et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients , 1982, Journal of the Neurological Sciences.
[34] Michael Garwood,et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.
[35] A. Imperato,et al. Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats , 1989, Neuroscience Letters.
[36] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[37] Clifford R Jack,et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] Y. Boulanger,et al. Role of phospholipase A2 on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases 1 1 Published on the World Wide Web on 10 August 2000. , 2000, Brain Research Reviews.
[39] R. Quirion,et al. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. , 2002, Progress in neurobiology.
[40] Frank M LaFerla,et al. Alzheimer's disease: Abeta, tau and synaptic dysfunction. , 2005, Trends in molecular medicine.